Circulation
... effects of thermal vasodilation in CHF, we studied 34 patients with chronic CHF (mean age, 58 +/- 14 years). Clinical stages were New York Heart Association functional class II in 2, III in 19, and IV in 13 patients. Mean ejection fraction was 25 +/- 9%. After a Swan-Ganz catheter was inserted via t ...
... effects of thermal vasodilation in CHF, we studied 34 patients with chronic CHF (mean age, 58 +/- 14 years). Clinical stages were New York Heart Association functional class II in 2, III in 19, and IV in 13 patients. Mean ejection fraction was 25 +/- 9%. After a Swan-Ganz catheter was inserted via t ...
Entering and Exiting the blood
... Events are same for Cardiac Cycle for Right Side of Heart; only difference is lower systolic pressures in right atrium and right ventricle. ...
... Events are same for Cardiac Cycle for Right Side of Heart; only difference is lower systolic pressures in right atrium and right ventricle. ...
Cardiac-specific antibodies in dilated cardiomyopathy
... flexible 50 Amt fiber optics have beer, developed and are currently in clinical use . Secondly, in the percutaneous application of these devices . the catheters arc routinely advanced over firmer 0.018 in . (0 .036 cm) guide wires under fluoroscopic guidance in order to provide more support and to m ...
... flexible 50 Amt fiber optics have beer, developed and are currently in clinical use . Secondly, in the percutaneous application of these devices . the catheters arc routinely advanced over firmer 0.018 in . (0 .036 cm) guide wires under fluoroscopic guidance in order to provide more support and to m ...
September 2011 - American Heart Association
... health care providers may consider surgically implanting an ICD that monitors the heart rate and rhythm and can deliver shocks to correct VT/VF if necessary. ICDs have been shown to reduce mortality from sudden cardiac arrest after a MI. Several trials have found improved survival rates with ICD the ...
... health care providers may consider surgically implanting an ICD that monitors the heart rate and rhythm and can deliver shocks to correct VT/VF if necessary. ICDs have been shown to reduce mortality from sudden cardiac arrest after a MI. Several trials have found improved survival rates with ICD the ...
Diastolic Heart Failure
... arterial stiffness, or both can cause a substantial increase in LA and pulmonary venous pressures and may result in acute pulmonary edema. NEJM 2004;351:1097-1105 ...
... arterial stiffness, or both can cause a substantial increase in LA and pulmonary venous pressures and may result in acute pulmonary edema. NEJM 2004;351:1097-1105 ...
sympTOmATOlOgy AnD sTRuCTuRAl HeART AbnORmAlITIes In
... (ECG) finding which may or may not be associated with overt heart disease at the time of diagnosis. This study was conducted to determine the pattern of clinical presentation and structural abnormalities in heart as diagnosed on Transthoracic Echocardiography in patients with left bundle branch bloc ...
... (ECG) finding which may or may not be associated with overt heart disease at the time of diagnosis. This study was conducted to determine the pattern of clinical presentation and structural abnormalities in heart as diagnosed on Transthoracic Echocardiography in patients with left bundle branch bloc ...
2012 ACCF/AHA/HRS Focused Update of the
... CRT may be considered for pts. who have LVEF ≤ 30%, ischemic HF etiology SR, LBBB with a QRS duration ≥ 150 ms, and NYHA class I symptoms on GDMT. (Level of Evidence: C) CRT may be considered for pts. who have LVEF ≤ 35%, SR, a non-LBBB pattern with QRS duration 120 to 149 ms, and NYHA class III/amb ...
... CRT may be considered for pts. who have LVEF ≤ 30%, ischemic HF etiology SR, LBBB with a QRS duration ≥ 150 ms, and NYHA class I symptoms on GDMT. (Level of Evidence: C) CRT may be considered for pts. who have LVEF ≤ 35%, SR, a non-LBBB pattern with QRS duration 120 to 149 ms, and NYHA class III/amb ...
VALVULAR HEART DISEASE
... PATHOPHYSIOLOGY. Aortic valve stenosis produces a pressure over load on the left ventricle due to the greater pressure that must be generated to force blood past the stenotic valve . a. Obstruction to out flow causes pressure over load and left ventricle hypertrophy b. Hypertrophy increases thick n ...
... PATHOPHYSIOLOGY. Aortic valve stenosis produces a pressure over load on the left ventricle due to the greater pressure that must be generated to force blood past the stenotic valve . a. Obstruction to out flow causes pressure over load and left ventricle hypertrophy b. Hypertrophy increases thick n ...
Coordination of the cardiac cycle. ECG
... excitation over atria wall (pacemaker) SAN sinoatrial node • Patch of tissue at the base of atrium/top of septum of heart where wave of excitation is delayed and which conducts electrical excitation from atria to septum AVN atrioventricular node • specialised muscle fibres in septum which conduct el ...
... excitation over atria wall (pacemaker) SAN sinoatrial node • Patch of tissue at the base of atrium/top of septum of heart where wave of excitation is delayed and which conducts electrical excitation from atria to septum AVN atrioventricular node • specialised muscle fibres in septum which conduct el ...
Outpatient Heart Failure Management
... – Education improves knowledge, self-monitoring, mediation adherence, days in hospital, and time to ...
... – Education improves knowledge, self-monitoring, mediation adherence, days in hospital, and time to ...
The Heart - WordPress.com
... There are valves between the atria and the ventricles… …and there are valves leading out of the ventricles. 9 of 49 ...
... There are valves between the atria and the ventricles… …and there are valves leading out of the ventricles. 9 of 49 ...
TandemHeart for Right Ventricular Failure
... system for RV support, dual groin access is not ideally suited to the needs of ambulatory LVAD patients. As a result, CardiacAssist has developed a dual lumen cannula for RV support through a single access site in the neck, with commercial release expected in early 2014 (Figure 2). Blood is still wi ...
... system for RV support, dual groin access is not ideally suited to the needs of ambulatory LVAD patients. As a result, CardiacAssist has developed a dual lumen cannula for RV support through a single access site in the neck, with commercial release expected in early 2014 (Figure 2). Blood is still wi ...
Management of Acute Myocardial Infarction
... Consult cardiologist for all patients requiring IABP. However, in our unit, if patients are going for prompt surgical revascularization or if patient belongs to the cardiac surgical unit, the cardiac surgeons will insert the IABP. Thrombolysis Decision for thrombolysis should be discussed with the o ...
... Consult cardiologist for all patients requiring IABP. However, in our unit, if patients are going for prompt surgical revascularization or if patient belongs to the cardiac surgical unit, the cardiac surgeons will insert the IABP. Thrombolysis Decision for thrombolysis should be discussed with the o ...
thrombolytic therapy in acute myocardial infarction
... 150 (50%) did not receive SK therapy because they did not qualify. Mean age was 55 years. The success of SK therapy was judged indirectly through non-invasive measures. LIMITATIONS: This data is from a hospital which does not have invasive or PCI facilities, hence it was totally dependant on non-inv ...
... 150 (50%) did not receive SK therapy because they did not qualify. Mean age was 55 years. The success of SK therapy was judged indirectly through non-invasive measures. LIMITATIONS: This data is from a hospital which does not have invasive or PCI facilities, hence it was totally dependant on non-inv ...
Chapter 12, Part 2 – The Heart The Heart is a Double Pump
... Path of Blood Through Heart! Right and left ventricles pump the same amount of blood each minute.! Left ventricular wall is thicker and develops higher pressures. (Why does this make sense?)! All valves open and close in response to pressure.! Papillary muscle and chordae tendineae prevent eversion ...
... Path of Blood Through Heart! Right and left ventricles pump the same amount of blood each minute.! Left ventricular wall is thicker and develops higher pressures. (Why does this make sense?)! All valves open and close in response to pressure.! Papillary muscle and chordae tendineae prevent eversion ...
Circulatory Disorders and Technologies
... proteins present that indicate heart damage. Then the patient is hooked up to an electrocardiograph which monitors the electrical impulses in the heart and provides a printout called an electrocardiogram (ECG) that shows if the heart is beating normally. ...
... proteins present that indicate heart damage. Then the patient is hooked up to an electrocardiograph which monitors the electrical impulses in the heart and provides a printout called an electrocardiogram (ECG) that shows if the heart is beating normally. ...
Bios 1310 Exam II Review Which layer consists of cardiac muscle
... 9. If a patient’s heart rate is 45 bpm… what can the nurse assume? a. The patient is tachycardic and the SA node is acting as pacemaker b. The patient is bradycardic and the SA node is acting as pacemaker c. The patient is tachycardic and the AV node is acting as pacemaker d. The patient is bradyca ...
... 9. If a patient’s heart rate is 45 bpm… what can the nurse assume? a. The patient is tachycardic and the SA node is acting as pacemaker b. The patient is bradycardic and the SA node is acting as pacemaker c. The patient is tachycardic and the AV node is acting as pacemaker d. The patient is bradyca ...
Peripartum cardiomyopathy
... • Patients with severe heart failure despite maximal drug therapy need cardiac transplantation to survive and to improve their quality of life • However, fewer than 3,000 hearts are available for transplantation worldwide per year • Therefore, ventricular assist devices are indicated as a bridge to ...
... • Patients with severe heart failure despite maximal drug therapy need cardiac transplantation to survive and to improve their quality of life • However, fewer than 3,000 hearts are available for transplantation worldwide per year • Therefore, ventricular assist devices are indicated as a bridge to ...
Элективный курс “Увлекательная кардиология”
... Weber-Janicki classes of heart failure (peakVO2); international classification of functional limitation (NYHA class); diagnostic procedures in the patient with known or suspected HF; importance of co-morbidities for prognosis of HF; prognostic evaluation of the heart failure patient; medical managem ...
... Weber-Janicki classes of heart failure (peakVO2); international classification of functional limitation (NYHA class); diagnostic procedures in the patient with known or suspected HF; importance of co-morbidities for prognosis of HF; prognostic evaluation of the heart failure patient; medical managem ...
Does Less Lung = More Heart?
... CPET done baseline and 6 months O2 pulse and pulse pressure were outcomes ...
... CPET done baseline and 6 months O2 pulse and pulse pressure were outcomes ...
ventricular fibrillation in acute myocardial infarction
... countries because its first expression is at the same time the last one. Ventricle tachycardia, the monomorphous and the polymorphous ones, and ventricular fibrillation are rhythm disorders that are most frequently associated with the phenomenon of sudden cardiac death. Ventricular fibrillation is t ...
... countries because its first expression is at the same time the last one. Ventricle tachycardia, the monomorphous and the polymorphous ones, and ventricular fibrillation are rhythm disorders that are most frequently associated with the phenomenon of sudden cardiac death. Ventricular fibrillation is t ...
peripartum cardiomyopathy
... • Patients with severe heart failure despite maximal drug therapy need cardiac transplantation to survive and to improve their quality of life • However, fewer than 3,000 hearts are available for transplantation worldwide per year • Therefore, ventricular assist devices are indicated as a bridge to ...
... • Patients with severe heart failure despite maximal drug therapy need cardiac transplantation to survive and to improve their quality of life • However, fewer than 3,000 hearts are available for transplantation worldwide per year • Therefore, ventricular assist devices are indicated as a bridge to ...
Afib - Ronna
... commonest drug for control of AF IV onset of action is 30 minutes maximal response occur in 1 to 4 hours loading dose 0.1 to 0.6 mg additional doses as needed 0.1 to 0.25 mg every 4 to 6 hours ƒ total dose in 24 hours is 1 mg ...
... commonest drug for control of AF IV onset of action is 30 minutes maximal response occur in 1 to 4 hours loading dose 0.1 to 0.6 mg additional doses as needed 0.1 to 0.25 mg every 4 to 6 hours ƒ total dose in 24 hours is 1 mg ...
Cardiac contractility modulation
.jpg?width=300)
Cardiac contractility modulation (CCM) is a treatment for patients with moderate to severe left ventricular systolic heart failure (NYHA class II–IV). The short- and long-term use of this therapy enhances both the strength of ventricular contraction and the heart’s pumping capacity. The CCM mechanism is based on stimulation of the cardiac muscle by non-excitatory electrical signals (NES). CCM treatment is delivered by a pacemaker-like device that applies the NES, adjusted to and synchronized with the electrical action in the cardiac cycle.In CCM therapy, electrical stimulation is applied to the cardiac muscle during the absolute refractory period. In this phase of the cardiac cycle, electrical signals cannot trigger new cardiac muscle contractions, hence this type of stimulation is known as a non-excitatory stimulation. However, the electrical CCM signals increase the influx of calcium ions into the cardiac muscle cells (cardiomyocytes). In contrast to other electrical stimulation treatments for heart failure, such as pacemaker therapy or implantable cardioverter defibrillators (ICD), CCM does not affect the cardiac rhythm directly. Rather, the aim is to enhance the heart’s natural contraction (the native cardiac contractility) sustainably over long periods of time. Furthermore, unlike most interventions that increase cardiac contractility, CCM is not associated with an unfavorable increase in oxygen demand by the heart (measured in terms of Myocardial Oxygen Consumption or MVO2). This may be explained by the beneficial effect CCM has in improving cardiac efficiency. A meta-analysis in 2014 and an overview of device-based treatment options in heart failure in 2013 concluded that CCM treatment is safe, that it is generally beneficial to patients and that CCM treatment increases the exercise tolerance (ET) and quality of life (QoL) of patients. Furthermore, preliminary long-term survival data shows that CCM is associated with lower long-term mortality in heart failure patients when compared with expected rates among similar patients not treated with CCM.